Swiss SMI down -0.56% at 7817.46 in Zurich 09:03:19 CET
Xetra Dax 30 up 0.1% at 5,708.66 in Frankfurt 09:19 CET
CAC 40 opens down -0.2% at 4,902.70 in Paris 09:03 CET
FTSE 100 opens up 0.2% at 5,772.8 in London 08:02 GMT
FTSE 250 down -0.1% at 9,319.0 in London 08:43 GMT
European bourses set for bouyant startEurope’s bourses are seen starting higher on Monday after Wall Street climbed late on on Friday as the price of oil fell below $62 a barrel and the euro hit a six-week low against the dollar. Spread betters in London are calling the FTSE 100, CAC 40, and DAX indexes to open between 7 and 19 points higher. ...more..
Bourses edge ahead as oil easesEurope’s bourses started slightly higher on Monday after Wall Street climbed late on on Friday as the price of oil fell below $62 a barrel and the euro hit a six-week low against the dollar. The FTSE Eurofirst 300 rose 0.1 per cent to 1,325.40 with the CAC-40 up 0.1 per cent to 4,914.54 and the FTSE 100 0.2 per cent ahead at 5,777.1. ...more...
FTSE climbs as BAA rises on hopes for 900p/share bidLONDON,, Feb 13 (Reuters) - Britain's top shares edged higher on Monday, with BAA (BAA.L: Quote, Profile, Research) in the lead after newspapers reported that the airport operator's top shareholders would agree to a bid from Spain's Gruppo Ferrovial (FER.MC: Quote, Profile, Research) of 900 pence a share. BAA's shares were up 1.3 percent at 788 pence -- a 14 percent discount to 900 pence a share. Last week sources told Reuters that the UK firm plans to vigorously defend itself against a potential Grupo Ferrovial bid.
By 0818 GMT the FTSE 100 share index <.FTSE> was up 13 points at 5,777.1, having ended last week at 5,764.1.
Mining stocks crowded the list of blue-chip and mid-cap fallers after commodities prices weakened. Rio Tinto (RIO.L: Quote, Profile, Research) was the top FTSE 100 faller, down 1.3 percent, while Antofagasta (ANTO.L: Quote, Profile, Research), BHP Billiton (BLT.L: Quote, Profile, Research) and Xstrata (XTA.L: Quote, Profile, Research) each shed about 1 percent. Among mid-caps, Indian miner Vedanta (VED.L: Quote, Profile, Research) stood out with a 1.4 percent drop.
But easing crude oil prices helped jet-fuel consumer British Airways (BAY.L: Quote, Profile, Research) gain 1.2 percent.
Elsewhere on the upside, shares in Barclays (BAY.L: Quote, Profile, Research) added 1.3 percent after Barron's business weekly reported that Britain's third-biggest bank could rise 15 percent to 20 percent as investors realise that fears about loan quality and profits are overblown.
While company results were thin on the ground, investors were gearing up for key domestic inflation data coming later this week for further direction on UK interest rates.
...more...European stocks steady; Barclays gains, Roche dipsLONDON, Feb 13 (Reuters) - European shares were steady on Monday, supported by a late rally on Wall Street, while oil shares BP (BP.L: Quote, Profile, Research) and Total (TOTF.PA: Quote, Profile, Research) ticked higher. Barclays (BARC.L: Quote, Profile, Research) rose 1 percent after business weekly Barron's said shares in the UK bank could rise 15 percent to 20 percent over the next 12 to 18 months as investors realise that fears about loan quality and profits are overblown.
By 0820 GMT, the pan-European FTSEurofirst index <.FTEU3> of 300 leading shares was up little changed at 1,324.5 points. The index is up nearly 4 percent this year, with gains driven by takeover speculation surrounding many companies.
Steel maker ThyssenKrupp (TKAG.DE: Quote, Profile, Research) fell 0.7 percent to 19.6 euros after the German industrial conglomerate reported a 20 percent fall in first-quarter pretax profit. "ThyssenKrupp reached the consensus and has had a good order backlog in Q1, which should be seen as positive," said a trader. "On the other hand, the whole sector has had a good run, especially on back of the Mittal/Arcelor/Dofasco soap operas. Therefore, watch out for profit taking," he said.
Roche (ROG.VX: Quote, Profile, Research) was a standout loser, down 2 percent after the drugmaker temporarily suspended recruitment of patients into a clinical trial assessing its colon cancer drug Avastin with conventional chemotherapy, due to safety concerns.
Clariant (CLN.VX: Quote, Profile, Research) rallied 8 percent as newspaper SonntagsZeitung reported on Sunday that the Swiss chemicals maker had entered into advanced sale talks, with private-equity firms being the likely buyers.
...more...